Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
Eli Lilly and Company
Canadian Cancer Trials Group
Beijing Biotech
Exscientia AI Limited
Zumutor Biologics Inc.
Arcus Biosciences, Inc.
Sotio Biotech Inc.
Eli Lilly and Company
National Cancer Institute (NCI)
Rondo Therapeutics
University of Southern California
Atavistik Bio, Inc
AstraZeneca
Merck Sharp & Dohme LLC
PMV Pharmaceuticals, Inc
Mayo Clinic
Alterome Therapeutics, Inc.
BeOne Medicines
Genmab
Tizona Therapeutics, Inc
City of Hope Medical Center
Ocellaris Pharma, Inc.
Apollo Therapeutics Ltd
Innate Pharma
Dren Bio
Novartis
OncoNano Medicine, Inc.
University Medical Center Groningen
NeoTX Therapeutics Ltd.
BicycleTx Limited
Bolt Biotherapeutics, Inc.
BicycleTx Limited
Nuvation Bio Inc.
National Cancer Institute (NCI)
Nanobiotix
ITM Oncologics GmbH
Janux Therapeutics
Maastricht University Medical Center
Institut Bergonié
Sichuan Baili Pharmaceutical Co., Ltd.
Scancell Ltd
Nurix Therapeutics, Inc.
A2 Biotherapeutics Inc.
Exelixis
Incyte Corporation
Merck Sharp & Dohme LLC
Cancer Research UK
Xencor, Inc.